BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15957176)

  • 1. Novel rearrangement of chromosome band 22q11.2 causing 22q11 microdeletion syndrome-like phenotype and rhabdoid tumor of the kidney.
    Wieser R; Fritz B; Ullmann R; Müller I; Galhuber M; Storlazzi CT; Ramaswamy A; Christiansen H; Shimizu N; Rehder H
    Hum Mutat; 2005 Aug; 26(2):78-83. PubMed ID: 15957176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic?
    Fuller CE; Pfeifer J; Humphrey P; Bruch LA; Dehner LP; Perry A
    Hum Pathol; 2001 Oct; 32(10):1102-8. PubMed ID: 11679945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic and molecular analysis of a t(1;22)(p36;q11.2) in a rhabdoid tumor with a putative homozygous deletion of chromosome 22.
    Rosty C; Peter M; Zucman J; Validire P; Delattre O; Aurias A
    Genes Chromosomes Cancer; 1998 Feb; 21(2):82-9. PubMed ID: 9491318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakpoint Associated with a novel 2.3 Mb deletion in the VCFS region of 22q11 and the role of Alu (SINE) in recurring microdeletions.
    Uddin RK; Zhang Y; Siu VM; Fan YS; O'Reilly RL; Rao J; Singh SM
    BMC Med Genet; 2006 Mar; 7():18. PubMed ID: 16512914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of meiotic recombination in 22q11.2, a region that frequently undergoes deletions and duplications.
    Torres-Juan L; Rosell J; Sánchez-de-la-Torre M; Fibla J; Heine-Suñer D
    BMC Med Genet; 2007 Apr; 8():14. PubMed ID: 17397557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic assessment of atypical deletions reveals genotype-phenotype correlation in 22q11.2.
    Rauch A; Zink S; Zweier C; Thiel CT; Koch A; Rauch R; Lascorz J; Hüffmeier U; Weyand M; Singer H; Hofbeck M
    J Med Genet; 2005 Nov; 42(11):871-6. PubMed ID: 15831592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
    Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
    Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Goldenhar phenotype in a child with distal 22q11.2 deletion and intracranial atypical teratoid rhabdoid tumor.
    Lafay-Cousin L; Payne E; Strother D; Chernos J; Chan M; Bernier FP
    Am J Med Genet A; 2009 Dec; 149A(12):2855-9. PubMed ID: 19938088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical deletion of 22q11.2: detection using the FISH TBX1 probe and molecular characterization with high-density SNP arrays.
    Beaujard MP; Chantot S; Dubois M; Keren B; Carpentier W; Mabboux P; Whalen S; Vodovar M; Siffroi JP; Portnoï MF
    Eur J Med Genet; 2009; 52(5):321-7. PubMed ID: 19467348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microduplication 22q11.2: a new chromosomal syndrome.
    Portnoï MF
    Eur J Med Genet; 2009; 52(2-3):88-93. PubMed ID: 19254783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor.
    Jackson EM; Shaikh TH; Gururangan S; Jones MC; Malkin D; Nikkel SM; Zuppan CW; Wainwright LM; Zhang F; Biegel JA
    Hum Genet; 2007 Sep; 122(2):117-27. PubMed ID: 17541642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors.
    Schofield DE; Beckwith JB; Sklar J
    Genes Chromosomes Cancer; 1996 Jan; 15(1):10-7. PubMed ID: 8824720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent microdeletion and duplication of 22q11.2.
    Blennow E; Lagerstedt K; Malmgren H; Sahlén S; Schoumans J; Anderlid B
    Clin Genet; 2008 Jul; 74(1):61-7. PubMed ID: 18445048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
    Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
    Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrowing the critical region for a rhabdoid tumor locus in 22q11.
    Biegel JA; Allen CS; Kawasaki K; Shimizu N; Budarf ML; Bell CJ
    Genes Chromosomes Cancer; 1996 Jun; 16(2):94-105. PubMed ID: 8818656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical heterogeneity of the chromosome 22q11 microdeletion syndrome].
    Muñoz S; Garay F; Flores I; Heusser F; Talesnik E; Aracena M; Mellado C; Méndez C; Arnaiz P; Repetto G
    Rev Med Chil; 2001 May; 129(5):515-21. PubMed ID: 11464533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis.
    Shaikh TH; Kurahashi H; Saitta SC; O'Hare AM; Hu P; Roe BA; Driscoll DA; McDonald-McGinn DM; Zackai EH; Budarf ML; Emanuel BS
    Hum Mol Genet; 2000 Mar; 9(4):489-501. PubMed ID: 10699172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies.
    Beauchesne LM; Warnes CA; Connolly HM; Ammash NM; Grogan M; Jalal SM; Michels VV
    J Am Coll Cardiol; 2005 Feb; 45(4):595-8. PubMed ID: 15708709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic alterations and gene expression profile of a malignant rhabdoid tumor of the kidney.
    Nagata T; Takahashi Y; Ishii Y; Asai S; Sugahara-Kobayashi M; Nishida Y; Murata A; Yamamori S; Ogawa Y; Nakamura T; Murakami H; Nakamura M; Shichino H; Chin M; Sugito K; Ikeda T; Koshinaga T; Mugishima H
    Cancer Genet Cytogenet; 2005 Dec; 163(2):130-7. PubMed ID: 16337855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1.5 Mb de novo 22q11.21 microduplication in a patient with cognitive deficits and dysmorphic facial features.
    Alberti A; Romano C; Falco M; Calì F; Schinocca P; Galesi O; Spalletta A; Di Benedetto D; Fichera M
    Clin Genet; 2007 Feb; 71(2):177-82. PubMed ID: 17250668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.